Edge Therapeutics Appoints Dr. Sol Barer and Isaac Blech as Chairman and Vice Chairman of Its Board of Directors
1/23/2013 9:03:22 AM
More...
|
Edge Therapeutics Appoints Drug-Delivery Luminary Dr. Robert Langer to Chair Scientific Advisory Committee
8/22/2012 9:16:33 AM
More...
|
Government of Canada Awards CA$700,000 Toward Phase 2 Study of Edge Therapeutics's Lead Compound to Improve Outcomes After Brain Injury
6/11/2012 9:30:34 AM
More...
|
MPI Research and Edge Therapeutics Partner to Advance Development of Life-Saving Therapies After Brain Hemorrhage
4/3/2012 10:06:12 AM
More...
|
Edge Therapeutics Receives Success Award From New Jersey Small Business Development Centers
12/5/2011 9:14:49 AM
More...
|
Edge Therapeutics Appoints James J. Loughlin to Board of Directors
11/17/2011 9:11:12 AM
More...
|
Edge Therapeutics to Present at Rodman & Renshaw's 13th Annual Healthcare Conference
9/7/2011 9:28:36 AM
More...
|
Edge Therapeutics Appoints Dr. Sol J. Barer to Board of Directors
9/7/2011 9:25:38 AM
More...
|
Edge Therapeutics Release: NimoGel(TM) Shows Promise at Preventing Delayed Complications of Sudden Brain Injury in a Preclinical Study Presented at the International Stroke Conference
2/14/2011 8:38:20 AM
More...
|
SurModics Inc. (SRDX) and Edge Therapeutics Collaborate on Development of Sustained-Release Neurological Product
11/4/2010 8:30:15 AM
More...
|
|